NEXGEL, Inc. (NXGL) stock
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$3.80−0.13 (-3.31%)
Close on Nov 17, 2026Market cap $37.04MP/E –Yield –
Nexgel EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Nexgel
Nexgel has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?